A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490315A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
12/29/2004	EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination
12/29/2004	EP1490093A1 Methods and compositions for the treatment of ischemia
12/29/2004	EP1490089A1 Peptides selectively lethal to malignant and transformed mammalian cells
12/29/2004	EP1490082A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
12/29/2004	EP1490081A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/29/2004	EP1490080A1 A process for the extraction of anthocyanins from black rice and composition thereof
12/29/2004	EP1490078A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
12/29/2004	EP1490077A1 A photoprotective orally administrable composition for skin
12/29/2004	EP1490072A1 Novel therapeutical use of agonist ligands specific to g2a receptor
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490063A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
12/29/2004	EP1490057A1 Method for treating cognitive disorders
12/29/2004	EP1490055A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
12/29/2004	EP1490053A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
12/29/2004	EP1490050A2 Methods for alzheimer's disease treatment and cognitive enhancement
12/29/2004	EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1490042A2 Use of ltb4 antagonists in veterinary medicine
12/29/2004	EP1490041A1 Treatment of female sexual dysfunction
12/29/2004	EP1490037A1 Taste masked veterinary solid compositions
12/29/2004	EP1490033A1 No-donating nsaids adsorbed into carrier particles
12/29/2004	EP1490030A1 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2004	EP1490029A1 Controlled release drug delivery system of pravastatin
12/29/2004	EP1490025A2 Nanoparticulate compositions of map kinase inhibitors
12/29/2004	EP1490013A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/29/2004	EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
12/29/2004	EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004	EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1343516A4 Analogues of thiocoraline and be-22179
12/29/2004	EP1311265B1 Pharmaceutical compositions for treating neurological disorders
12/29/2004	EP1287827B1 Immunopotentiator
12/29/2004	EP1282612B1 Alkynyl phenyl heteroaromatic glucokinase activators
12/29/2004	EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1263723A4 Ningalin b analogs employable for reversing multidrug resistance
12/29/2004	EP1242114A4 Use of enzymes for skin expansion
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines
12/29/2004	EP1226138B1 Fab i inhibitors
12/29/2004	EP1226136B1 Tyrosine kinase inhibitors
12/29/2004	EP1225882A4 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
12/29/2004	EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor
12/29/2004	EP1196616B1 Replication-competent anti-cancer vectors
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1148059B1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP1066037B1 Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
12/29/2004	EP1062321B1 Uses for humane non-autologous mesenchymal stem cells
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP1045691B1 Statin-carboxyalkylether combinations
12/29/2004	EP1003745B1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
12/29/2004	EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0915701B1 Fast-dissolving galanthamine hydrobromide tablet
12/29/2004	EP0885211B1 Compounds with a sulfamate group
12/29/2004	EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1559047A DNA providing system
12/29/2004	CN1558915A Leukocyte inactivation module
12/29/2004	CN1558906A Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558903A Water-soluble phenylpyridazine compounds and compositions containing the same
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558894A Method for the nitration of phenolic compounds
12/29/2004	CN1558772A Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
12/29/2004	CN1558770A Method of preventing cell death using segments of neural thread proteins
12/29/2004	CN1558766A A method of reducing the 'in vivo' cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (HDL) and low density lipoproteins (LDL)
12/29/2004	CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies
12/29/2004	CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558756A Pharmaceutical compositions for the treatment of urinary disorders
12/29/2004	CN1557833A Eplerenone crystalline form exhibiting enhanced dissolution rate
12/29/2004	CN1557429A Sunstroke treating medicine
12/29/2004	CN1557342A Antisenescent and sexual function improving preparation
12/29/2004	CN1557340A Growth factor and immuneglobin preparation
12/29/2004	CN1557296A Gingko lactone freeze dried powder injection and its preparation method
12/29/2004	CN1182143C Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents
12/29/2004	CN1182136C Novel pyrrolo-(3,4-B) quinoline derivatives, method for prodn. and use thereof as medicament
12/29/2004	CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
12/29/2004	CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CN1182117C Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
12/29/2004	CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004	CN1181860C Chinese-medicinal injection for promoting growth of pig and its preparing process
12/29/2004	CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/29/2004	CA2529462A1 An agent for improving physiological motor functions
12/29/2004	CA2529288A1 Composition for lowering serum uric acid level
12/29/2004	CA2529268A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/28/2004	US6835826 Acid resistance, stability; telomerase inhibitor
12/28/2004	US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt

1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 1564